Vicore Pharma Holding AB (VCRE)
Vicore Pharma Holding AB operates in the Biotechnology industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $9.59, down 2.14% on the session, giving a market capitalisation of $270.9M. On trailing twelve-month figures it carries a trailing P/E of -4.85, a net margin of -12569.8%. Its beta of 0.15 implies it has historically moved less than the broad market.
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
Vicore Pharma Holding AB is most often compared with the following Healthcare names: